Vanguard disaggregates holdings; AtriCure (NASDAQ: ATRC) shows 0 shares
Rhea-AI Filing Summary
AtriCure Inc Schedule 13G/A Amendment No. 6: The Vanguard Group reports beneficial ownership of 0 shares of Common Stock, representing 0%. The filing notes an internal realignment on January 12, 2026 that disaggregated reporting by Vanguard subsidiaries. The amendment is signed by Ashley Grim on 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Amendment clarifies Vanguard's disaggregated reporting; no beneficial stake reported.
The filing explicitly states 0 shares beneficially owned and 0% of the class, reflecting the post‑realignment reporting structure described in SEC Release No. 34-39538.
Timing and cash‑flow treatment are not relevant here; subsequent filings by Vanguard subsidiaries may show any holdings separately.
FAQ
Does The Vanguard Group own AtriCure (ATRC) shares after this amendment?
What does the January 12, 2026 realignment mean in the 13G/A?
Who signed the Schedule 13G/A amendment for ATRC?
Will separate Vanguard entities file their own disclosures for ATRC?